Page last updated: 2024-09-04

moxifloxacin and Cirrhosis

moxifloxacin has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, SW; Chen, TC; Wang, TY	1

Other Studies

1 other study(ies) available for moxifloxacin and Cirrhosis

Article	Year
Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation. British journal of pharmacology, 2013, Volume: 168, Issue:6 Topics: Actin Cytoskeleton; Anti-Bacterial Agents; Aza Compounds; Cell Transdifferentiation; Cells, Cultured; Endothelium, Corneal; Epithelium, Corneal; Fibrosis; Fluoroquinolones; Humans; Moxifloxacin; Myofibroblasts; Osmolar Concentration; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Quinolines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Recombinant Proteins; Smad2 Protein; Smad7 Protein; Topoisomerase Inhibitors; Transforming Growth Factor beta1; Wound Healing	2013

Article

Year

Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation.

British journal of pharmacology, 2013, Volume: 168, Issue:6

Topics: Actin Cytoskeleton; Anti-Bacterial Agents; Aza Compounds; Cell Transdifferentiation; Cells, Cultured; Endothelium, Corneal; Epithelium, Corneal; Fibrosis; Fluoroquinolones; Humans; Moxifloxacin; Myofibroblasts; Osmolar Concentration; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Quinolines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Recombinant Proteins; Smad2 Protein; Smad7 Protein; Topoisomerase Inhibitors; Transforming Growth Factor beta1; Wound Healing

2013